Postoperative pT-stage (%) | |
Carcinoma in situ | 4 (6.5) |
T0 | 6 (9.7) |
T1 | 5 (8) |
T2 | 23 (37.1) |
T3 | 18 (29) |
T4 | 6 (9.7) |
Postoperative grade (%) | |
Low | 0 (0) |
High | 56 (100) |
pN stage (%) | |
N0 | 47 (75.8) |
N+ | 15 (24.2) |
Lymph node count (range) | 22.9 (8 to 46) |
Positive margins, % | 6.4 |
Concomitant prostate cancer (%) | 14 (22.6) |
Gleason score (%) | |
Gleason 6 | 9 (64.3) |
Gleason 7a (Gleason 3 + 4) | 4 (28.6) |
Gleason 7b (Gleason 4 + 3) | 1 (7.1) |
Positive margins (prostate) | 7.1% |